Not Yet Recruiting
A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
NCT07664735
- Conditions
- Adnexal Diseases, Advanced Endometrial Cancer, Endocrine Gland Neoplasms, +22 more
- Locations
-
Not specified